As we ready ourselves for another day of relaxation with the short people, we thought it may be helpful to pass along a few items as you wind down the work week or continue your own vacation. Whatever your plans, we hope you enjoy.....
James Orlowski may not be the only doctor in the Tampa Bay, Florida, area who has given sales reps the boot. But he's the only regional doc listed in the online directory of No Free Lunch, an organization opposed to accepting freebies from pharma, The St. Petersburg Times writes. Orlowski tells the paper that when he was a med student at Case Western Reserve University 33 years ago, no one discussed the ethics of accepting drug company gifts, and freebies like medical instruments and textbooks were hard to resist. "Then I saw research that showed these gifts have tremendous influence on prescribing practices, though physicians always deny it," Orlowski says. "There's no way I was going to let a drug company gift influence my decisionmaking."
From peasant doctor to ceo of a fledgling biotech, Hu Fang's rise parallels China's economic transformation. At age 19, he was a "barefoot doctor," ordered by the government to the frigid, mountainous province of Heilongjiang in northern China from his home near Shanghai, Bloomberg News writes. He was one of thousands of students sent to the countryside in the 1960s with little training and few supplies to care for the poorest Chinese. Now 57, Hu runs Shanghai Sunway Biotech, one of only two companies in the world to sell a gene-therapy treatmens. Hu's career reflects the rise of China's drug industry from marketers of herbal treatments to research-based companies exploiting advances that have fueled health-care breakthroughs in the U.S. and Europe. He is also benefiting from intellectual property laws that are less restrictive than in the West, lower costs and different regulations for human testing.
Ohio Supreme Court Upholds Damages Law (Associated Press)
Schering-Plough Warns R&D Costs Will Rise (Yahoo/Associated Press)
Mylan Gets OK To Ship Generic Zyrtec (Reuters)
Endo Buys Rights To Alexza's Inhailed Painkiller (Bloomberg News)